Your browser doesn't support javascript.
loading
CKS protein overexpression renders tumors susceptible to a chemotherapeutic strategy that protects normal tissues.
Tat, John; Loriot, Céline; Henze, Martha; Spruck, Charles; Felding, Brunhilde H; Reed, Steven I.
Affiliation
  • Tat J; Department of Molecular Medicine, The Scripps Research Institute, CA 92037, La Jolla, San Diego, USA.
  • Loriot C; Present address: Department of Medicine, University of California, San Diego, La Jolla, 92093-0652, California, San Diego, USA.
  • Henze M; Department of Molecular Medicine, The Scripps Research Institute, CA 92037, La Jolla, San Diego, USA.
  • Spruck C; Department of Molecular Medicine, The Scripps Research Institute, CA 92037, La Jolla, San Diego, USA.
  • Felding BH; Tumor Initiation and Maintenance Program, Cancer Center, Sanford-Burnham-Prebys Medical Discovery Institute, La Jolla, 92037, CA, San Diego, USA.
  • Reed SI; Department of Molecular Medicine, The Scripps Research Institute, CA 92037, La Jolla, San Diego, USA.
Oncotarget ; 8(70): 114911-114923, 2017 Dec 29.
Article in En | MEDLINE | ID: mdl-29383129
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States